Landscapes / Targets

IL-1β

5 drugs act on IL-1β, in 14 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs5

DrugHow it worksCompanyStageNext dateDetails
Interleukin-1 receptor antagonist
Approved —
Monoclonal antibody
AbbVie · Public ABBV
Phase 3 Dec 2026Phase 3 trial completes
Multi-specific immunoglobulin
Phase 2 22 Apr 2027Phase 2 trial completes
—
Phase 2 30 Jun 2027Phase 2 trial completes
—
3SBio · Public 1530.HK
Phase 2 11 Aug 2027Phase 2 trial completes

About this list

Checked
5 of 5 drugs. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow IL-1β

Following is part of Solo: you see every change to IL-1β the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in